Comparative Effectiveness of Vancomycin and Metronidazole for C difficile Infection | Gastroenterology | JAMA Internal Medicine | The JAMA Network

This propensity-matched cohort study evaluates the risk of recurrence and all-cause 30-day mortality in patients receiving metronidazole or vancomycin for mild to moderate and severe Clostridium difficile infection.

Source: Comparative Effectiveness of Vancomycin and Metronidazole for C difficile Infection | Gastroenterology | JAMA Internal Medicine | The JAMA Network